STAT

APRIL 29, 2025

The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options.  Businesses are changing prescriptions, mixing in additives, or encouraging stockpiling of existing compounded products. Some have disappeared altogether.

Compounding 332

Compounding Compounding Pharmacies Diabetes 332

Express Pharma

JANUARY 14, 2025

The Indian nutraceutical market is set to grow sixfold by 2030 Kalka Prasad, AVP – Marketing, Crius Life, Crius Group The Indian nutraceutical market is projected to reach $64 billion by 2030. per cent from 2024 to 2030. billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.3

Diabetes 105

Diabetes Compounding 105

Express Pharma

MAY 13, 2025

Children and young people (CYP) living in low- and middle-income countries (LMICs) face gross inequities when it comes to the diagnosis and treatment of type 1 diabetes (T1D). Without sustainable access to diabetes care, they are unable to manage this chronic condition, leading to severe outcomes that are entirely preventable.

Diabetes 89

Diabetes Biosimilars Compounding 89

Express Pharma

MAY 30, 2024

In the APAC region, several factors contribute to the increasing prevalence of neurological disorders, including ageing populations, lifestyle changes, and the rising incidence of risk factors such as hypertension and diabetes.” billion in 2030, with a compound annual growth rate (CAGR) of 117.6 These include Eisai Co.

Compounding 115

Compounding Diabetes Pharmaceutical Companies Pharmaceutical Companies 115

Pharmacy Times

JUNE 18, 2025

The Healthy People 2030 initiative addresses structural health care inequalities and implements programs to ameliorate SDOH. Each unique set of economic, educational, social, and environmental circumstances significantly affects their quality of life and health.

Pharmacy Technician 26

Pharmacy Technician Immunity Immunization Diabetes 26

PharmD Live

MAY 13, 2024

Their projections indicate that approximately 10,000 people will turn 65 each day over the next 19 years, with the population of older adults expected to double to 80 million by 2030. At this rate, nearly half of the older population could be impacted by polypharmacy by 2030. Data from the U.S. in 1994 to 42.4%

Long-Term Care Facilities 105

Long-Term Care Facilities Diabetes Nursing Homes Prescription Filling 105

Pharmacy Times

JUNE 9, 2025

2019;380:2020-2030. Global Initiative for Asthma. Accessed June 9, 2025. Beasley R, Holliday M, Reddell HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med.

Pharmacy Technician 29

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management 29